(Q78049567)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11991556%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

title

Factors affecting compliance with allergen immunotherapy at a military medical center (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11991556%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

0 references

1 reference

Daniel R More

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11991556%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

Larry L Hagan

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11991556%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

publication date

1 April 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11991556%20AND%20SRC:MED&resulttype=core&format=json

Annals of Allergy, Asthma & Immunology

10 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11991556%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

volume

88

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11991556%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11991556%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

page(s)

391-394

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11991556%20AND%20SRC:MED&resulttype=core&format=json

The Hymenoptera venom study. III: Safety of venom immunotherapy.

10 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962370-8

7 January 2021

Determinants of patient compliance with allergen immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962370-8

7 January 2021

Drug therapy: patient compliance.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962370-8

7 January 2021

Clinical and immunologic studies of rapid venom immunotherapy in Hymenoptera-sensitive patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962370-8

7 January 2021

Hymenoptera venom immunotherapy. II. T proliferative and T suppressive activities induced by Vespula immunotherapy: effects on long-term antibody responses

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962370-8

7 January 2021

Safety of a two-day ultrarush insect venom immunotherapy protocol in comparison with protocols of longer duration and involving a larger number of injections

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962370-8

7 January 2021

Rapid Hymenoptera venom immunotherapy: comparative safety of three protocols.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962370-8

7 January 2021

Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. I. Rush immunotherapy with allergoids and standardized orchard grass-pollen extract

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962370-8

7 January 2021

Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. Systemic reactions during the rush protocol in patients suffering from asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962370-8

7 January 2021

10.1016/S1081-1206(10)62370-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11991556%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

1 reference